News
Swiss Deep Tech News & Analysis
Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.
Curated Newsfeed
-
Vaderis Therapeutics closes USD 152 million Series B Financing
startupticker.ch
-
Terra Quantum partners with Apex.AI on quantum-safe security
startupticker.ch
-
AB2 Bio receives USD 30 million from Nippon Shinyaku
startupticker.ch
DTN Highlights
-
Read more: swisscanto: A Matter of ScaleThe Flywheel Switzerland Hasn’t Built Roughly seventy percent of the Swiss Growth Fund’s money is invested in Switzerland, and Nils Granath is clear that this…
-
Read more: swisscanto: Backed to the FutureThree Companies That Almost Stopped Running Nils Granath invests in the growth stage of the Swiss market, and it is the part where the money…
-
Read more: swisscanto: At Face ValueThe Marathon Runner In the mid-1990s, the European mobile telecoms industry was hiring at a pace that was breaking its own buildings. Ericsson, the Swedish…
-
Read more: Swiss Venture Capital Steadies at $1.58 Billion in H1 2026 as Hardware Sets a RecordSwiss venture capital returned to a familiar level in the first half of 2026. Startups raised $1.58 billion (CHF 1.245 billion) across 123 financing rounds,…
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global EconomyThe technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor LayerSwiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space SummitESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of ScaleIn Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Read more: SICTIC: Backed to the FutureThomas Dübendorfer doesn’t invest like a portfolio manager optimizing for returns. He invests like a scout who found someone worth running alongside – and then…
-
CHF 39 million for BE WTR eco-friendly premium water solutions
BE WTR, the Swiss startup revolutionizing sustainable water solutions, just closed its CHF 39M Series C funding round. This new round of funding will accelerate BE…
startupticker.ch
startupticker.ch: CHF 39 million for BE WTR eco-friendly premium water solutions- BE WTR closed a CHF 39M Series C round led by Convent Capital to expand sustainable water solutions globally.
- The company operates compact on-site bottling plants in high-end venues, targeting over 20 locations by end-2025.
- BE WTR offers water activation and circular bottling as a sustainable alternative to traditional bottled water.
-
Lymphatica Medical raises €17.9 million in series B Funding
Lymphatica Medtech SA is a clinical-stage company based in Lausanne, specialized in innovative treatments for lymphedema, a chronic vascular condition that currently has no cure…
startupticker.ch
startupticker.ch: Lymphatica Medical raises €17.9 million in series B Funding- Lymphatica Medtech raised Series B funding to advance LymphoDrain, an implantable device for treating lymphedema.
- LymphoDrain is minimally invasive, implanted subcutaneously, and actively restores lymphatic vessel function.
- Dan Rose, former leader at LimFlow and Medtronic, joined as Chairman, strengthening the board.
-
€36 million to digitalise farming with xFarm’s platform
xFarm Technologies a Swiss-Italian startup dedicated to digitalising the agri-food sector, has raised €36 million in series C round. The funds will enable the company…
startupticker.ch
startupticker.ch: €36 million to digitalise farming with xFarm’s platform- xFarm supports 450,000+ farms across 100+ supply chains covering 7 million hectares using AI-powered data analysis and regenerative agriculture models.
- xFarm is creating a new Fintech and Insurtech division to enhance insurance and financial management services for farmers.
-
CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial
Somagenetix AG, a pioneering biotech company focussing on gene therapies for disorders affecting a type of white blood cells, raised CHF 10 million in a…
startupticker.ch
startupticker.ch: CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial- Somagenetix AG raised CHF 10M in Series A funding for SGX-001, a gene therapy for p47 Chronic Granulomatous Disease, targeting 2026 clinical trials.
- The company's lentiviral gene therapy platform offers a one-time treatment alternative to stem cell transplants for inherited immunodeficiencies.
- Dr. Andrin Oswald joined as CEO, bringing over 20 years of pharmaceutical leadership experience to guide clinical development.
-
FDA approvals and clinical advancements propel life sciences startups forward
Four startups are making strides in developing novel solutions for challenging medical conditions, potentially offering new hope for patients. Alentis Therapeutics and Abionic have received…
startupticker.ch
startupticker.ch: FDA approvals and clinical advancements propel life sciences startups forward- Alentis Therapeutics received FDA clearance for ALE.P02, an antibody-drug conjugate for CLDN1+ squamous cancers, with Phase 1/2 trials starting Q1 2025.
- Abionic's CAPSULE PSP test gained FDA approval for rapid sepsis detection in blood samples within five minutes, improving patient outcomes.
- Anokion's ANK-700 showed clinical proof of concept for treating relapsing-remitting multiple sclerosis by re-educating immune tolerance to myelin.
-
Voliro secures $12M in Series A funding to transform industrial inspections with drones
Voliro, a leading innovator in aerial mobile robotics, closed a $12 million in Series A funding round led by Cherry Ventures. The new funding will…
startupticker.ch
startupticker.ch: Voliro secures $12M in Series A funding to transform industrial inspections with drones- Voliro raised $12 million in Series A funding to expand aerial robotics for industrial inspection, maintenance, and repair work.
- Voliro's tiltable rotor drones enable non-destructive testing and contact-based inspections on hard-to-reach infrastructure.
- Voliro offers a B2B subscription model including hardware, software, training, support, and updates for customers.
-
Read more: b2venture: At Face ValueAndreas Goeldi from b2venture shares insights on scaling startups, bridging tech and business, and strengthening Switzerland’s deep tech ecosystem.
-
Read more: b2venture: Backed to the FutureFrom ETH labs to global markets: Andreas Goeldi backs Swiss deep tech startups like Ledgy and LatticeFlow AI, proving timing is everything.
-
Read more: b2venture: A Matter of ScaleFrom Zurich AI hubs to US expansion, Andreas Goeldi of b2venture shares how Swiss startups can scale abroad while keeping their European DNA intact.
-
Read more: Dragan Grabulovski: Serial EntrepreneurAntibody-drug conjugates (ADCs) allow cytotoxic drugs to bind specifically to cancer cells with the aim of destroying them. The process is not new, but to…
-
Read more: All Eyes on SwitzerlandThe number of exits in Switzerland is rising again. Swiss technology companies are no longer being acquired solely for their technology and team, but increasingly…
-
Read more: Decoding the 2025 Top 100 Swiss Startup AwardLast night, the Swiss innovation ecosystem gathered under the bright lights of the ZSC Swiss Life Arena in Zürich, a major ice hockey stadium. The…
-
Read more: Into the Web with DTN’s Spider Analysis: Where We’re Strong, Where We’re Slow, and What To Do About ItOur new spider graph maps Switzerland’s position across four pillars of deep tech: Innovation & IP, Academia, Ecosystem, and Capital & Investment. A clear picture…
-
Read more: From Momentum to Mission: What the Latest VC-Trends Mean for Deep Tech in SwitzerlandThis mid-year reading of startupticker.ch and SECA’s Swiss VC Report takes the surface rebound—a healthy rise in invested capital—and weighs it against quieter signals: fewer…
-
Read more: Globally Unique Focus on Deep TechThe first Swiss Deep Tech Report presents data-driven evidence of the advantages that make Switzerland a global deep tech hotspot. It also provides an in-depth…
-
Read more: Deep Tech Nation CEO in Le Temps: “If We Want Economic Giants, We Must Wake Up”Our CEO, Joanne Sieber, recently sat down with the influential Swiss newspaper Le Temps to discuss a critical challenge for the nation’s future: financing the…
-
Read more: Microsoft’s USD 400 Million Bet on Swiss AIMicrosoft has confirmed a four-hundred-million-dollar programme to expand its Swiss cloud and AI footprint, launch a national accelerator for startups and SMEs, and equip 100…
-
Read more: AI Pioneers in the Life Sciences SectorSwitzerland’s strong life sciences sector is a pace setter in combining traditional approaches from the pharma and medtech industries with AI. Several start-ups have recently…
